Back

Hypertrophic cardiomyopathy phenotype associated with concomitant gla, ttr and prkag2 variants in an amazonian adolescent

28 August 2026 (11:21 - 11:33)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: from diagnosis to therapy Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Isabella Peterlini Valsi

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail
Early haemodynamic response but persistent systolic dysfunction after mavacamten interruption in obstructive hypertrophic cardiomyopathy (oHCM): a pharmacist led titration case
Miss D. Lakhani (London, GB)
Slides Video
Presentation thumbnail
A young female patient with massive LVH and dual-level obstructive HCM: a case report on the successful use of mavacamten and future management planning
Doctor D. Da Silva Correia (Lisbon, PT)
Slides Video
Presentation thumbnail
Unusual genetics in hypertrophic cardiomyopathy: looking beyond autosomal dominant inheritance
Doctor S. Rivas Garcia (Madrid, ES)
Slides Video
Presentation thumbnail
Mavacamten for worsening left ventricular outflow tract obstruction after TAVI in a patient with hypertrophic cardiomyopathy
Mr M. Takeuchi (Nankoku, JP)
Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: from diagnosis to therapy
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:21 CET
You may be interested in
thumbnail
Congress Session
Hypertrophic cardiomyopathies: challenges in diagnosis
30 August 2025
thumbnail
Congress Presentation
Non-sarcomeric (metabolic) HCM in an octogenarian patient: an unexpected very late-diagnosis of VLCAD Deficiency
28 August 2026
thumbnail
Congress Presentation
Clinical and genetic characteristics of pediatric hypertrophic cardiomyopathy in japan: a multicenter study with validation of sudden cardiac death risk models
29 August 2026
thumbnail
Congress Presentation
When relief turns risk: a case of mavacamten overexposure in obstructive HCM.
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources